A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
Autor: | Raez LE, Papadopoulos K, Ricart AD, Chiorean EG, Dipaola RS, Stein MN, Rocha Lima CM, Schlesselman JJ, Tolba K, Langmuir VK, Kroll S, Jung DT, Kurtoglu M, Rosenblatt J, Lampidis TJ |
---|---|
Zdroj: | Cancer Chemotherapy & Pharmacology; Feb2013, Vol. 71 Issue 2, p523-530, 8p |
Databáze: | Complementary Index |
Externí odkaz: |